Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptidesi

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Fleisher Berkovich, Sigal ^a   Filipovich Rimon, Talia ^a   Ben Shmuel, Sarit ^a   Hülsmann, Claudia ^b   Kummer, Markus P ^b   Heneka, Michael T ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; CYCLOOXYGENASE 2; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4;

ANIMAL CELL; ARTICLE; BRAIN FUNCTION; CELL ACTIVATION; CELL LINE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MICROGLIA; MOUSE; NERVE DEGENERATION; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CELL MOTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CYCLOOXYGENASE 2; IMMUNOHISTOCHEMISTRY; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; RECEPTORS, BRADYKININ; RECEPTORS, ENDOTHELIN; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957684460     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-61     Document Type: Article

References (47)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010, 362(4):329-344. 10.1056/NEJMra0909142, 20107219.
2. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140(6):918-934. 10.1016/j.cell.2010.02.016, 2873093, 20303880.
3. Fliers E, Swaab DF. Neuropeptide changes in aging and Alzheimer's disease. Prog Brain Res 1986, 70:141-152. full_text, 2883702.
4. Hayashi M, Yamashita A, Shimizu K. Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging. Brain Res 1997, 749(2):283-289. 10.1016/S0006-8993(96)01317-0, 9138728.
5. Duchene J, Ahluwalia A. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease. Curr Opin Pharmacol 2009, 9(2):125-131. 10.1016/j.coph.2008.11.011, 19124274.
6. Kumar U, Grant M. Somatostatin and somatostatin receptors. Results Probl Cell Differ 2010, 50:137-184. full_text, 19859675.
7. Minami M, Kimura M, Iwamoto N, Arai H. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19(3):509-513. 10.1016/0278-5846(95)00031-P, 7624501.
8. Burgos-Ramos E, Hervás-Aguilar A, Aguado-Llera D, Puebla-Jiménez L, Hernández-Pinto AM, Barrios V, et al. Somatostatin and Alzheimer's disease. Mol Cell Endocrinol 2008, 286(1-2):104-111. 10.1016/j.mce.2008.01.014, 18359553.
9. Yoshizawa T, Iwamoto H, Mizusawa H, Suzuki N, Matsumoto H, Kanazawa I. Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type. Neuropeptides 1992, 22(2):85-88. 10.1016/0143-4179(92)90059-6, 1407412.
10. Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 1980, 288(5788):279-280. 10.1038/288279a0, 6107862.
11. Raidoo DM, Bhoola KD. Kinin receptors on human neurones. J Neuroimmunol 1997, 77(1):39-44. 10.1016/S0165-5728(97)00048-9, 9209266.
12. Corrêa FM, Innis RB, Uhl GR, Snyder SH. Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain. Proc Natl Acad Sci USA 1979, 76(3):1489-1493. 10.1073/pnas.76.3.1489, 383279, 375238.
13. Johansson O, Hökfelt T, Elde RP. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 1984, 13(2):265-339. 10.1016/0306-4522(84)90233-1, 6514182.
14. Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol 1986, 27(1):63-100. 10.1016/0301-0082(86)90012-2, 2874591.
15. Wulfsen I, Meyerhof W, Fehr S, Richter D. Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary. J Neurochem 1993, 61(4):1549-1552. 10.1111/j.1471-4159.1993.tb13654.x, 8377006.
16. Epelbaum J, Guillou J, Gastambide F, Hoyer D, Duron E, Viollet C. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?. Prog Neurobiol 2009, 89(2):153-161. 10.1016/j.pneurobio.2009.07.002, 19595735.
17. Grouselle D, Winsky-Sommerer R, David JP, Delacourte A, Dournaud P, Epelbaum J. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett 1998, 255(1):21-24. 10.1016/S0304-3940(98)00698-3, 9839717.
18. Slama A, Heidet V, Cervera P, Hirsch E, Javoy-Agid F, Epelbaum J. Preservation of Somatostatin Receptors Coupled to the Inhibition of Adenylate Cyclase in the Cortex and Hippocampus in Senile Dementia of the Alzheimer Type. Dementia 1991, 2(2):88-94.
19. Epelbaum J, Dournaud P, Fodor M, Viollet C. The neurobiology of somatostatin. Crit Rev Neurobiol 1994, 8(1-2):25-44.
20. Krantic S, Robitaille Y, Quirion R. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease. Brain Res 1992, 573(2):299-304. 10.1016/0006-8993(92)90776-6, 1354549.
21. Noda M, Kettenmann H, Wada K. Anti-inflammatory effects of kinins via microglia in the central nervous system. Biol Chem 2006, 387(2):167-171. 10.1515/BC.2006.022, 16497148.
22. Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S, et al. Kinin receptors in cultured rat microglia. Neurochem Int 2004, 45(2-3):437-442. 10.1016/j.neuint.2003.07.007, 15145558.
23. Khimji A, Rockey DC. Endothelin-Biology and disease. Cell Signal 2010, 22(11):1615-1625. 10.1016/j.cellsig.2010.05.002, 20466059.
24. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 2000, 293(2):607-617.
25. Hanisch U, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10(11):1387-1394. 10.1038/nn1997, 17965659.
26. Carnevale D, De Simone R, Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol Disord Drug Targets 2007, 6(6):388-397. 10.2174/187152707783399193, 18220778.
27. Biber K, Neumann H, Inoue K, Boddeke HWGM. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci 2007, 30(11):596-602. 10.1016/j.tins.2007.08.007, 17950926.
28. Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, et al. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci USA 2010, 107(13):6058-6063. 10.1073/pnas.0909586107, 2851853, 20231476.
29. Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S, et al. Expression and function of bradykinin receptors in microglia. Life Sci 2003, 72(14):1573-1581. 10.1016/S0024-3205(02)02449-9, 12551746.
30. Feindt J, Schmidt A, Mentlein R. Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells. Brain Res Mol Brain Res 1998, 60(2):228-233. 10.1016/S0169-328X(98)00184-3, 9757047.
31. Kessler IM, Pacheco YG, Lozzi SP, de Araújo AS, Onishi FJ, de Mello PA. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 2005, 64(Suppl 1 S1):2-5. discussion S1:5.
32. Zhang WW, Badonic T, Höög A, Jiang MH, Ma KC, Nie XJ, et al. Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin- 1. J Neurol Sci 1994, 122(1):90-96. 10.1016/0022-510X(94)90057-4, 8195809.
33. Jiang MH, Höög A, Ma KC, Nie XJ, Olsson Y, Zhang WW. Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport 1993, 4(7):935-937. 10.1097/00001756-199307000-00024, 8369484.
34. Berelowitz M, Dudlak D, Frohman LA. Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones. J Clin Invest 1982, 69(6):1293-1301. 10.1172/JCI110569, 370202, 7045160.
35. Ifuku M, Färber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, et al. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 2007, 27(48):13065-13073. 10.1523/JNEUROSCI.3467-07.2007, 18045900.
36. Mietkiewski E, Lichota E, Legiecka B, Pałgan E, Staniszewski L, Pietrzak-Nowacka M. Effects of kinins, kallikrein and its inhibitor on certain indices of cell-mediated immunity and humoral immunity in rabbits. Acta Physiol Pol 1980, 31(1):71-79.
37. Ahmed AA, Wahbi AH, Nordlin K. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immunotoxicol 2001, 23(3):397-409. 10.1081/IPH-100107339, 11694030.
38. Reinikainen KJ, Riekkinen PJ, Jolkkonen J, Kosma VM, Soininen H. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease. Brain Res 1987, 402(1):103-108. 10.1016/0006-8993(87)91052-3, 3828777.
39. Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NP. Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci 1982, 31(19):2073-2079. 10.1016/0024-3205(82)90099-6, 6184590.
40. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang S, et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 2005, 11(4):434-439. 10.1038/nm1206, 15778722.
41. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009, 73(10):768-774. 10.1212/WNL.0b013e3181b6bb95, 2848584, 19738171.
42. Ifuku M, Färber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, et al. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 2007, 27(48):13065-13073. 10.1523/JNEUROSCI.3467-07.2007, 18045900.
43. Ahmed AA, Wahbi A, Nordlind K, Kharazmi A, Sundqvist KG, Mutt V, et al. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol 1998, 48(1):79-85. 10.1046/j.1365-3083.1998.00380.x, 9714414.
44. Lee CYD, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm 2010, 117(8):949-960. 10.1007/s00702-010-0433-4, 20552234.
45. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 2001, 32(2):177-180. 10.1016/S0896-6273(01)00475-5, 11683988.
46. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998, 273(49):32730-32738. 10.1074/jbc.273.49.32730, 9830016.
47. Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem 2007, 101(2):397-410. 10.1111/j.1471-4159.2006.04339.x, 17402969.